Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
At the 31st International Conference of Alzheimer’s Disease International (ADI), held in Budapest, Hungary, from April 21–24 2016, Anders Wimo MD, PhD, from Karolinska Institutet, Stockholm, Sweden, explains the challenges of the development of disease-modifying therapies to intervene during the earliest stages of dementia.